CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.680
-0.090 (-1.89%)
At close: Mar 6, 2026, 4:00 PM EST
4.641
-0.039 (-0.84%)
After-hours: Mar 6, 2026, 7:40 PM EST
CytomX Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$8.86
Upside
+89.32%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $6 → $10 | Buy | Maintains | $6 → $10 | +113.68% | Feb 4, 2026 |
| Barclays | Barclays | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +113.68% | Feb 4, 2026 |
| Barclays | Barclays | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +70.94% | Jan 20, 2026 |
| Guggenheim | Guggenheim | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +113.68% | Jan 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $6.5 → $10 | Buy | Maintains | $6.5 → $10 | +113.68% | Jan 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +113.68% | Nov 11, 2025 |
| Barclays | Barclays | Buy Maintains $3.5 → $6 | Buy | Maintains | $3.5 → $6 | +28.21% | Oct 21, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $6 | Buy | Initiates | $6 | +28.21% | Sep 22, 2025 |
| Barclays | Barclays | Buy Initiates $3.5 | Buy | Initiates | $3.5 | -25.21% | Sep 17, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $7 | Buy | Initiates | $7 | +49.57% | Jul 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +6.84% | May 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $2.5 → $5 | Buy | Maintains | $2.5 → $5 | +6.84% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $5 | Hold → Strong Buy | Upgrades | $5 | +6.84% | May 15, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $3.25 → $2.5 | Buy | Maintains | $3.25 → $2.5 | -46.58% | Apr 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.